Tempus AI, Inc. (NASDAQ:TEM) Given Average Rating of “Moderate Buy” by Analysts

Tempus AI, Inc. (NASDAQ:TEM) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $48.67.

TEM has been the topic of a number of research analyst reports. Loop Capital lifted their target price on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Piper Sandler started coverage on Tempus AI in a research note on Monday, August 12th. They issued a “neutral” rating and a $40.00 price objective on the stock. Longbow Research started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $48.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Finally, Stifel Nicolaus began coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price on the stock.

Tempus AI Stock Down 1.3 %

Shares of NASDAQ:TEM opened at $48.68 on Thursday. The firm has a fifty day simple moving average of $52.58. Tempus AI has a 52 week low of $22.89 and a 52 week high of $77.00. The company has a quick ratio of 3.52, a current ratio of 3.70 and a debt-to-equity ratio of 4.50.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to the consensus estimate of $159.10 million. On average, equities analysts forecast that Tempus AI will post -6.51 EPS for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

A number of large investors have recently bought and sold shares of TEM. Sandia Investment Management LP bought a new stake in Tempus AI in the second quarter valued at $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI during the third quarter worth about $258,000. Clarus Group Inc. acquired a new stake in shares of Tempus AI in the 3rd quarter worth about $283,000. Northwestern University bought a new stake in Tempus AI in the 2nd quarter valued at about $491,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Tempus AI in the second quarter valued at approximately $633,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.